PECAM1 and neoplasm: Silencing CBS increases the expression of angiogenesis inhibitor SERPINF1 and inhibits the expression of Ki67, CD31, CD34, and hypoxia‐inducible factor (HIF‐1α), and reduces GSH synthesis enhanced oxidative stress, thereby inhibiting tumour cell growth.